We conducted an initial filtering step to ensure that all datasets contained clinical-level metrics such as ER Status (Positive or Negative), ERBB2 positive, cancer grade, death, cancer subtype (PAM50), and years to outcome. This evidence concerns the gene ERBB2 and cancer.